Tóth, Z.; Lőczi, L.; Sebők, B.; Merkely, P.; Keszthelyi, E.; Lintner, B.; Ács, N.; Keszthelyi, A.; Várbíró, S.; Tóth, R.;
et al. Neutrophil/Lymphocyte Ratio (NLR) as a Predictive Marker for p16 Positivity and Cervical Cancer Progression: Insights from the SCOPE Study. Cancers 2025, 17, 921.
https://doi.org/10.3390/cancers17060921
AMA Style
Tóth Z, Lőczi L, Sebők B, Merkely P, Keszthelyi E, Lintner B, Ács N, Keszthelyi A, Várbíró S, Tóth R,
et al. Neutrophil/Lymphocyte Ratio (NLR) as a Predictive Marker for p16 Positivity and Cervical Cancer Progression: Insights from the SCOPE Study. Cancers. 2025; 17(6):921.
https://doi.org/10.3390/cancers17060921
Chicago/Turabian Style
Tóth, Zsófia, Lotti Lőczi, Barbara Sebők, Petra Merkely, Emese Keszthelyi, Balázs Lintner, Nándor Ács, Attila Keszthelyi, Szabolcs Várbíró, Richárd Tóth,
and et al. 2025. "Neutrophil/Lymphocyte Ratio (NLR) as a Predictive Marker for p16 Positivity and Cervical Cancer Progression: Insights from the SCOPE Study" Cancers 17, no. 6: 921.
https://doi.org/10.3390/cancers17060921
APA Style
Tóth, Z., Lőczi, L., Sebők, B., Merkely, P., Keszthelyi, E., Lintner, B., Ács, N., Keszthelyi, A., Várbíró, S., Tóth, R., & Keszthelyi, M.
(2025). Neutrophil/Lymphocyte Ratio (NLR) as a Predictive Marker for p16 Positivity and Cervical Cancer Progression: Insights from the SCOPE Study. Cancers, 17(6), 921.
https://doi.org/10.3390/cancers17060921
